Cargando…
Secondary Prevention of Diabetes Type 1 with Oral Calcitriol and Analogs, the PRECAL Study
Screening for Type 1 Diabetes (T1D, incidence 1:300) with T1D autoantibodies (T1Ab) at ages 2 and 6, while sensitive, lacks a preventive strategy. Cholecalciferol 2000 IU daily since birth reduced T1D by 80% at 1 year. T1D-associated T1Ab negativized within 0.6 years with oral calcitriol in 12 child...
Autores principales: | Papadimitriou, Dimitrios T., Dermitzaki, Eleni, Christopoulos, Panagiotis, Papagianni, Maria, Kleanthous, Kleanthis, Marakaki, Chrysanthi, Papadimitriou, Anastasios, Mastorakos, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217040/ https://www.ncbi.nlm.nih.gov/pubmed/37238410 http://dx.doi.org/10.3390/children10050862 |
Ejemplares similares
-
FRI608 Secondary Prevention Of Diabetes Type 1 With Oral Calcitriol And Analogs, The Precal Study
por: Papadimitriou, Dimitrios T, et al.
Publicado: (2023) -
Successful Treatment of Severe Atopic Dermatitis with Calcitriol and Paricalcitol in an 8-Year-Old Girl
por: Bothou, Christina, et al.
Publicado: (2018) -
Anastrozole Improves Near Adult Height in Boys With Compromised Height Potential, as Monotherapy or in Combination With a GnRH Analogue
por: Papadimitriou, Dimitrios T, et al.
Publicado: (2021) -
OR15-05 Gain in Near Adult Height Using the Combination of an LHRH Analogue and an Aromatase Inhibitor in Early Maturing Girls with Compromised Growth. The “Gail” Study ISRCTN11469487
por: Papadimitriou, Dimitrios T, et al.
Publicado: (2020) -
MON-541 Successful Treatment of Normocalcemic Hyperparathyroidism in Children
por: Papadimitriou, Dimitrios, et al.
Publicado: (2019)